KETOROLAC

This brand name is authorized in Nigeria.

Active ingredients

The drug KETOROLAC contains one active pharmaceutical ingredient (API):

1	Ketorolac UNII 4EVE5946BQ - KETOROLAC TROMETHAMINE
	Ketorolac is a non-steroidal anti-inflammatory agent demonstrating analgesic and anti-inflammatory activity. Ketorolac inhibits the cyclo-oxygenase enzyme essential for biosynthesis of prostaglandins. Ketorolac has been shown to reduce prostaglandin levels in the aqueous humour after topical ophthalmic administration.
	Read more about Ketorolac

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-1843	Solution for injection	Ketorolac Injection INJ_SOL 30 mg/2 mL 2 mL x 10's (in ampoules)	Solution for injection	28/09/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AB15	Ketorolac	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-1843